FDA Endangers Women’s Health Approving Over-the-Counter Aborticidal Contraceptive (RAN)
On July 11, the FDA approved Opill, for sale over-the-counter. Peer-reviewed medical studies demonstrate that the once-a-day pill under consideration carries a “carcinogenic risk… at least comparable to the risk of [combined oral contraceptives].” The World Health Organization has listed oral contraceptives as Group 1 carcinogens along with plutonium, causing increased risk of breast cancer,